Dorothy McCabe

Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist

Barry Bresnihan, Jos� Maria Alvaro-Gracia, Mark Cobby et al. · Arthritis & Rheumatism · 1998 · 974 citations

Medicine, Immunology, Pharmacotherapy +16

Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin‐1 receptor antagonist, in combination with methotrexate: Results of a twenty‐four–week, multicenter, randomized, double‐blind, placebo‐controlled trial

Stanley Cohen, Eric R. Hurd, John J. Cush et al. · Arthritis & Rheumatism · 2002 · 647 citations

Medicine, Pharmacology, Pharmacotherapy +11

A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: Radiologic progression and correlation of genant and larsen scores

Yebin Jiang, Harry K. Genant, Iain Watt et al. · Arthritis & Rheumatism · 2000 · 403 citations

Medicine, Clinical Sciences, Pharmacotherapy +17

Long‐term safety and maintenance of clinical improvement following treatment with anakinra (recombinant human interleukin‐1 receptor antagonist) in patients with rheumatoid arthritis: Extension phase of a randomized, double‐blind, placebo‐controlled trial

George Nuki, Barry Bresnihan, Moraye B. Bear et al. · Arthritis & Rheumatism · 2002 · 228 citations

Medicine, Pharmacology, Pharmacotherapy +12

Awareness, Knowledge, and Perceptions of Biosimilars Among Specialty Physicians

Hillel P. Cohen, Donna Beydoun, David Chien et al. · Advances in Therapy · 2016 · 208 citations · Full text

Medicine, Clinical Sciences, Medical Education +13